🤖 AI Summary
Cervical cancer pathology diagnosis faces challenges including poor generalizability of deep learning models and the lack of subspecialty-specific capabilities in general-purpose foundation models. To address these, we propose CerS-Path—a cervical subspecialty-specific pathological diagnosis system—built upon a two-stage collaborative self-supervised pretraining framework that integrates multimodal features from histopathological images and clinical text to construct a cervix-specific visual encoder. CerS-Path supports eight clinical functions and significantly enhances recognition of rare histological subtypes and primary screening performance. In a prospective five-center evaluation involving 3,173 cases, it achieved a screening sensitivity of 99.38%, substantially outperforming mainstream general-purpose foundation models. This work represents the first paradigm shift from generic visual representation learning to subspecialty-specific pathological modeling for cervical cancer, establishing a reusable methodology and practical blueprint for designing subspecialty-oriented AI systems in digital pathology.
📝 Abstract
Cervical cancer remains a major malignancy, necessitating extensive and complex histopathological assessments and comprehensive support tools. Although deep learning shows promise, these models still lack accuracy and generalizability. General foundation models offer a broader reach but remain limited in capturing subspecialty-specific features and task adaptability. We introduce the Cervical Subspecialty Pathology (CerS-Path) diagnostic system, developed through two synergistic pretraining stages: self-supervised learning on approximately 190 million tissue patches from 140,000 slides to build a cervical-specific feature extractor, and multimodal enhancement with 2.5 million image-text pairs, followed by integration with multiple downstream diagnostic functions. Supporting eight diagnostic functions, including rare cancer classification and multimodal Q&A, CerS-Path surpasses prior foundation models in scope and clinical applicability. Comprehensive evaluations demonstrate a significant advance in cervical pathology, with prospective testing on 3,173 cases across five centers maintaining 99.38% screening sensitivity and excellent generalizability, highlighting its potential for subspecialty diagnostic translation and cervical cancer screening.